Managing Women's Health Issues: Across a Lifespan

Pasadena, California
Saturday, April 30, 2016
Managing Women’s Health Issues Across a Lifespan

Saturday, April 30, 2016

Sheraton Pasadena Hotel
Justines Ballroom
303 Cordova Street
Pasadena, California

8:15 AM – 9:00 AM Registration and Breakfast
9:00 AM – 3:45 PM Presentations


Advance Your Knowledge. Master Your Skill Set. 

Women’s health is complex and unique. It is imperative that women’s health nurse practitioners—who are at the forefront of caring for women throughout their lifespan—are up to date on guidelines and interventions for women’s top health concerns.  

Join your NP colleagues! This full-day activity will focus on the challenges you face caring for women throughout their lifespan. An interactive, case-based format will allow you to interact with faculty experts on:
  • Long-acting reversible contraception (LARC)
  • Endometriosis
  • Obesity
  • Genitourinary syndrome of menopause (GSM)
Don’t miss this opportunity to learn from the experts on how you can improve the health of your female patients. Please join us for an informative and interactive discussion and network with your NP colleagues! 

There is no fee to attend this activity, however, travel and lodging costs will be at your own expense. This activity is limited to 100 attendees.

Nurse practitioners (NPs), Certified Nurse-Midwives (CNMs), and other advanced practice clinicians who care for women.


6.5 Contact Hours of CE Credit, including 4.0 Contact Hours of Pharmacology Content

This live activity, Managing Women’s Health Issues Across a Lifespan, on April 30, 2016, has been evaluated and approved by the Continuing Education Approval Program of the National Association of Nurse Practitioners in Women’s Health for 6.5 contact hours of continuing education, including 4.0 contact hours of pharmacology content. Each participant should claim only those contact hours that he/she actually spent in the educational activity.

NPWH policy requires all faculty to disclose any affiliation or relationship with a commercial interest that may cause a potential, real, or apparent conflict of interest with the content of a CE program. NPWH does not imply that the affiliation or relationship will affect the content of the CE Program. Disclosure provides participants with information that may be important to their evaluation of an activity. Faculty are also asked to identify any unlabeled/unapproved uses of drugs or devices made in their presentation.

Click here to learn more about the program faculty.

NPWH policy requires authors to disclose to participants when presenting information about unlabeled use of a commercial product or device or an individual use of a drug or device not yet approved for any use.

Participating faculty members determine the editorial content of CE activities; this content does not necessarily represent the views of NPWH. This content has undergone a blinded peer review process for validation of clinical content. Although every effort has been made to ensure that the information is accurate, clinicians are responsible for evaluating this information in relation to generally accepted standards in their own communities and integrating the information in this activity with that of established recommendations of other authorities, national guidelines, FDA approved package inserts, and individual patient characteristics.

This educational activity is jointly provided by the National Association of Nurse Practitioners in Women’s Health (NPWH) and Spire Learning.

For additional information on this program please go to:

Supported by an educational grant from Takeda Pharmaceuticals International, Inc. U.S. Region, Teva Pharmaceuticals, and Shionogi, Inc.